PKCδ can induce resistance to tamoxifen and irradiation in cultured breast cancer cells [15,16] and has been shown to promote both metastasis [17-19] and proliferation [20] of murine mammary cancer and epithelial cells. Here, PRKCD is linked to breast cancer.